0.4305

3.91% -0.0175

After Hours: .45 0.0195 +4.53%

Scienture Holdings Inc (SCNX)

Overview News Price History Discussions Forecast

Scienture Holdings Inc stock is traded at $0.4305, with a volume of 413.88K. It is down -3.91% in the last 24 hours and down -20.29% over the past month. Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Previous Close:

$0.448

Open:

$0.448

24h Volume:

413.88K

Relative Volume:

0.27

Market Cap:

$17.49M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+0.12%

1M Performance:

-20.29%

6M Performance:

-79.40%

1Y Performance:

-85.70%

1-Day Range:

$0.4291

$0.4585

1-Week Range:

$0.4291

$0.4849

52-Week Range:

$0.4248

$3.61

Scienture Holdings Inc Stock (SCNX) Company Profile

Name

Scienture Holdings Inc

Sector

Healthcare (1112)

Industry

Pharmaceutical Retailers (9)

Phone

(800) 261 0281

Address

20 AUSTIN BLVD., COMMACK

Employee

Twitter

Next Earnings Date

Latest SEC Filings

SCNX's Discussions on Twitter

Compare SCNX vs HITI, PETS, RDGT, WGRX, POM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SCNX Scienture Holdings Inc	0.4305	18.20M	0	0	0	0.00
HITI High Tide Inc	2.31	204.67M	376.07M	-22.41M	18.73M	-0.298
PETS Petmed Express Inc	2.93	63.56M	270.52M	-6.08M	17.42M	-0.2944
RDGT Ridgetech Inc	1.69	32.53M	119.97M	-1.45M	632.50K	-0.9847
WGRX Wellgistics Health Inc	0.2812	32.09M	28.99M	-39.20M	-3.34M	0.00
POM Pomdoctor Ltd Adr	0.2364	28.32M	0	0	0	0.00

Scienture Holdings Inc Stock (SCNX) Latest News

Feb 09, 2026

Aug Levels: Is Scienture Holdings Inc stock heavily shortedWeekly Profit Analysis & Smart Swing Trading Alerts - baoquankhu1.vn

Feb 09, 2026

Feb 03, 2026

Scienture reports progress on ARBLI, confirms REZENOPY launch By Investing.com - Investing.com Nigeria

Feb 03, 2026

SCNX: Scienture Updates on Arbli and Future Product Launch - GuruFocus

Feb 03, 2026

Scienture reports progress on ARBLI, confirms REZENOPY launch - Investing.com

Feb 03, 2026

SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - The Manila Times

Feb 03, 2026

Scienture Provides Commercial Update on ARBLI , the First FDA-Approved Ready-To-Use Oral Suspension of Losartan Potassium - marketscreener.com

Feb 03, 2026

Nearly $385M at stake as Scienture grows ARBLI and readies overdose REZENOPY - Stock Titan

Feb 03, 2026

Jan 31, 2026

Signal Recap: Does InvenTrust Properties Corp stock have upside surprise potentialAnalyst Downgrade & Fast Exit/Entry Strategy Plans - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026

Is Scienture Holdings Inc gaining market share2025 Technical Overview & AI Enhanced Trading Signals - baoquankhu1.vn

Jan 30, 2026

Jan 21, 2026

Scienture appoints Hariharan, Mani as co-CEOs - MSN

Jan 21, 2026

Growth Value: Will Scienture Holdings Inc benefit from geopolitical trendsWeekly Trading Summary & Comprehensive Market Scan Insights - baoquankhu1.vn

Jan 21, 2026

Jan 20, 2026

EPS Watch: What is Scienture Holdings Incs book value per share2025 Technical Overview & Expert Approved Momentum Ideas - baoquankhu1.vn

Jan 20, 2026

Risk On: Is Scienture Holdings Inc stock heavily shortedMarket Risk Summary & Reliable Entry Point Alerts - baoquankhu1.vn

Jan 20, 2026

Jan 19, 2026

Will Scienture Holdings Inc. stock recover faster than peersQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - bollywoodhelpline.com

Jan 19, 2026

Jan 15, 2026

Aug Spikes: Is EHTH stock forming a cup and handleOil Prices & Free Accurate Trade Setup Notifications - baoquankhu1.vn

Jan 15, 2026

EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment - Sahm

Jan 15, 2026

Head to Head Review: Scienture (NASDAQ:SCNX) & Aldeyra Therapeutics (NASDAQ:ALDX) - Defense World

Jan 15, 2026

Scienture receives patent for high-dose naloxone nasal spray By Investing.com - Investing.com Nigeria

Jan 15, 2026

Jan 14, 2026

Scienture And Summit's REZENOPY Awarded Orange Book-Listable Patent, Valid Till 2041 - Nasdaq

Jan 14, 2026

SCNX Secures Patent for REZENOPY Nasal Spray Until 2041 - GuruFocus

Jan 14, 2026

Scienture receives patent for high-dose naloxone nasal spray - Investing.com

Jan 14, 2026

SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment - The Manila Times

Jan 14, 2026

New patent backs 10 mg naloxone spray for life-saving overdose treatment - Stock Titan

Jan 14, 2026

Jan 13, 2026

AI Stocks: Will Scienture Holdings Inc stock outperform international peersPortfolio Gains Report & Community Verified Swing Trade Signals - Bộ Nội Vụ

Jan 13, 2026

Jan 12, 2026

Aug PreEarnings: Will Escalade Incorporated stock hit new highs in YEAR - baoquankhu1.vn

Jan 12, 2026

Jan 10, 2026

MSN Money - MSN

Jan 10, 2026